Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CRHR1 | P34998 | 4/20 | 0.35 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 5/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.32 |
| ▸ | CTSB | P07858 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.30 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6049440 | 0.94 | P2RX7 (0.39) | CRHR1CRHR2P2RX7ALDH1A1LMNA | |
| SCHEMBL6049448 | 0.91 | KCNA5 (0.34) | CRHR1CRHR2P2RX7KMT2AALDH1A1 | |
| SCHEMBL6049379 | 0.89 | TSHR (0.33) | CRHR1CRHR2P2RX7KMT2AHSD17B10 | |
| SCHEMBL6049427 | 0.87 | CRHR1 (0.33) | CRHR1CRHR2P2RX7ALDH1A1LMNA | |
| SCHEMBL6049357 | 0.85 | SCN9A (0.31) | SCN9A | |
| SCHEMBL6049387 | 0.84 | SCN9A (0.33) | CRHR1CRHR2P2RX7KMT2AALDH1A1 | |
| SCHEMBL6049395 | 0.84 | SCN9A (0.34) | CRHR1CRHR2P2RX7KMT2AALDH1A1 | |
| SCHEMBL6049436 | 0.83 | SCN9A (0.42) | SCN9A | |
| SCHEMBL6049378 | 0.83 | SCN9A (0.35) | P2RX7ALDH1A1LMNASCN9ACTSB | |
| SCHEMBL6049359 | 0.83 | P2RX7 (0.33) | CRHR1CRHR2P2RX7ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1458237-B1 | HERBICIDAL MIXTURE BASED ON 7-PYRAZOLYLBENZOXAZOLES | BASF AG (DE) | 2006-04-12 | — | — | EP | claimed |
| US-20050037923-A1 | Herbicidal mixture based on 7-pyrazolybenzoxazoles | BASF AKTIENGESELLSCHAFT (DE) | 2005-02-17 | — | — | US | claimed |
| EP-1458237-B1 | HERBICIDAL MIXTURE BASED ON 7-PYRAZOLYLBENZOXAZOLES | BASF AG (DE) | 2006-04-12 | — | — | EP | disclosed |
| US-20050037923-A1 | Herbicidal mixture based on 7-pyrazolybenzoxazoles | BASF AKTIENGESELLSCHAFT (DE) | 2005-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050037923-A1 | Herbicidal mixture based on 7-pyrazolybenzoxazoles | DDT, CYP2W1, CYP3A7 | CRHR1 3847/4885CRHR2 4194/4885P2RX7 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.